GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction

P Alonso-Coello, HJ Schünemann, J Moberg… - bmj, 2016 - bmj.com
Healthcare decision making is complex. Decision-making processes and the factors
(criteria) that decision makers should consider vary for different types of decisions, including …

Cost-effectiveness analyses of lung cancer screening strategies using low-dose computed tomography: a systematic review

AJN Raymakers, J Mayo, S Lam, JM FitzGerald… - … health economics and …, 2016 - Springer
Background Lung cancer screening with low-dose computed tomography (LDCT) has been
shown to deliver appreciable reductions in mortality in high-risk patients. However, in an era …

Cost-effectiveness analysis of stereotactic body radiation therapy compared with radiofrequency ablation for inoperable colorectal liver metastases

H Kim, B Gill, S Beriwal, MS Huq, MS Roberts… - International Journal of …, 2016 - Elsevier
Purpose To conduct a cost-effectiveness analysis to determine whether stereotactic body
radiation therapy (SBRT) is a cost-effective therapy compared with radiofrequency ablation …

Heterogeneity in women's adherence and its role in optimal breast cancer screening policies

T Ayer, O Alagoz, NK Stout… - Management …, 2016 - pubsonline.informs.org
Most major health institutions recommend women to undergo repeat mammography
screening for early diagnosis of breast cancer, the leading cause of cancer deaths among …

Structural uncertainty of Markov models for advanced breast cancer: a simulation study of lapatinib

QA Le - Medical Decision Making, 2016 - journals.sagepub.com
Objective. To examine the impact of structural uncertainty of Markov models in modeling cost-
effectiveness for the treatment of advanced breast cancer (ABC). Methods. Four common …

Evaluation of health economics in radiation oncology: a systematic review

TK Nguyen, CD Goodman, RG Boldt, A Warner… - International Journal of …, 2016 - Elsevier
Purpose Despite the rising costs in radiation oncology, the impact of health economics
research on radiation therapy practice analysis patterns is unclear. We performed a …

Assessing cost-utility of predictive biomarkers in oncology: a streamlined approach

A Safonov, S Wang, CP Gross, D Agarwal… - Breast cancer research …, 2016 - Springer
Abstract Evaluation of cost-utility is critical in assessing the medical utility of predictive or
prognostic biomarkers. Current methods involve complex state-transition models, requiring …

Cost-effectiveness analysis of whole-mount pathology processing for patients with early breast cancer undergoing breast conservation

NJ Hong, GM Clarke, MJ Yaffe, CMB Holloway - Current Oncology, 2016 - mdpi.com
Background: Obtaining accurate histopathologic detail for breast lumpectomy specimens is
challenging because of sampling and loss of three-dimensional conformational features with …

Wirtschaftlichkeit des 21 Gene Tests in der Behandlung von Patientinnen mit nodal-positivem Mammakarzinom

L Fischer, M Arnold, F Kirsch, R Leidl - Das Gesundheitswesen, 2016 - thieme-connect.com
Ziel der Studie: Brustkrebs ist die häufigste Krebserkrankung von Frauen. Die meisten
Leitlinien empfehlen Patientinnen mit Lymphknoten-positivem (LN+) Brustkrebs im …

[图书][B] Analysis of Breast Cancer Screening Policies Using Partially Observable Markov Decision Processes

M Cevik - 2016 - search.proquest.com
In this dissertation, we study three aspects of the breast cancer screening problem: impact of
breast density and supplemental screenings, screening in resource-restricted settings and …